This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello and welcome to this Medscape InDiscussion on pulmonary arterial hypertension (PAH). Our topic today is the very important ...
Can a one-minute sit-to-stand test predict long-term outcomes in pulmonary hypertension? New data suggest it can. Read more.
Panelists discuss how disease progression monitoring requires integrating multiple data points including symptoms, six-minute walk tests, biomarkers like BNP/NT-proBNP, and imaging studies, with risk ...
Panelists discuss how riociguat targets the nitric oxide pathway and is approved for both Group 1 PAH and Group 4 chronic thromboembolic pulmonary hypertension, with specific patient selection ...
NOTCH3 protein levels identified idiopathic pulmonary arterial hypertension with over 90% accuracy, showing its potential as ...
An expert panel developed practical flowcharts to help U.S. healthcare providers with the diagnosis and treatment of ...
Novel Laser Intravascular Lithotripsy (L-IVL) System for Calcified Coronary Lesions: Procedural Success and Imaging Outcomes from the First-in-Human Experience (FastWave Medical) Receive the the ...
Women with preeclampsia had significantly higher median NT-proBNP levels compared with those with other hypertensive ...
Elevated maternal uric acid levels during early to mid-gestation are independently associated with an increased risk of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results